These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 25348020)
1. TXNL1 induces apoptosis in cisplatin resistant human gastric cancer cell lines. Ni P; Xu W; Zhang Y; Chen Q; Li A; Wang S; Xu S; Zhou J Curr Cancer Drug Targets; 2015; 14(9):850-9. PubMed ID: 25348020 [TBL] [Abstract][Full Text] [Related]
2. TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer. Xu W; Wang S; Chen Q; Zhang Y; Ni P; Wu X; Zhang J; Qiang F; Li A; Røe OD; Xu S; Wang M; Zhang R; Zhou J Cell Death Dis; 2014 Feb; 5(2):e1055. PubMed ID: 24525731 [TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis. Li M; Zhang YY; Shang J; Xu YD Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4185-4191. PubMed ID: 31173289 [TBL] [Abstract][Full Text] [Related]
4. JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells. Xu W; Chen Q; Wang Q; Sun Y; Wang S; Li A; Xu S; Røe OD; Wang M; Zhang R; Yang L; Zhou J Cell Death Dis; 2014 Dec; 5(12):e1551. PubMed ID: 25476899 [TBL] [Abstract][Full Text] [Related]
5. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells]. Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141 [TBL] [Abstract][Full Text] [Related]
6. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2. Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance. Zhang XW; Bu P; Liu L; Zhang XZ; Li J Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062 [TBL] [Abstract][Full Text] [Related]
8. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling. Fu D; Wang C; Yu L; Yu R Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867 [TBL] [Abstract][Full Text] [Related]
9. miR‑138‑5p modulates the expression of excision repair cross‑complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin. Ning J; Jiao Y; Xie X; Deng X; Zhang Y; Yang Y; Zhao C; Wang H; Gu K Oncol Rep; 2019 Feb; 41(2):1131-1139. PubMed ID: 30535472 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of miRNA-200c on chemotherapy-resistance and cell proliferation of gastric cancer SGC7901/DDP cells. Chen Y; Zuo J; Liu Y; Gao H; Liu W Chin J Cancer; 2010 Dec; 29(12):1006-11. PubMed ID: 21114921 [TBL] [Abstract][Full Text] [Related]
11. Celecoxib enhanced the cytotoxic effect of cisplatin in drug-resistant human gastric cancer cells by inhibition of cyclooxygenase-2. Xu HB; Shen FM; Lv QZ Eur J Pharmacol; 2015 Dec; 769():1-7. PubMed ID: 26407653 [TBL] [Abstract][Full Text] [Related]
12. [Ethoxysanguinarine directly targets CIP2A to inhibit proliferation and induce autophagy of SGC7901/DDP cells]. Wan F; Tan M; Xiang YC; Liu XW; Peng P; Liu Y Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(21):5890-5899. PubMed ID: 36472008 [TBL] [Abstract][Full Text] [Related]
13. Reversion of multidrug resistance by SKI-II in SGC7901/DDP cells and exploration of underlying mechanisms. Zhu ZA; Zhu ZQ; Cai HX; Liu Y Asian Pac J Cancer Prev; 2012; 13(2):625-31. PubMed ID: 22524836 [TBL] [Abstract][Full Text] [Related]
14. PEITC reverse multi-drug resistance of human gastric cancer SGC7901/DDP cell line. Tang T; Song X; Liu YF; Wang WY Cell Biol Int; 2014 Apr; 38(4):502-10. PubMed ID: 23956061 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway. Chen Z; Gao YJ; Hou RZ; Ding DY; Song DF; Wang DY; Feng Y Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):171-180. PubMed ID: 30657558 [TBL] [Abstract][Full Text] [Related]
16. LncRNA DANCR accelerates the development of multidrug resistance of gastric cancer. Xu YD; Shang J; Li M; Zhang YY Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2794-2802. PubMed ID: 31002130 [TBL] [Abstract][Full Text] [Related]
17. Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A/PP2A/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells. Liu X; Duan C; Ji J; Zhang T; Yuan X; Zhang Y; Ma W; Yang J; Yang L; Jiang Z; Yu H; Liu Y Oncol Rep; 2017 Jul; 38(1):271-278. PubMed ID: 28534965 [TBL] [Abstract][Full Text] [Related]
18. Depression of MAD2 inhibits apoptosis of gastric cancer cells by upregulating Bcl-2 and interfering mitochondrion pathway. Du Y; Yin F; Liu C; Hu S; Wang J; Xie H; Hong L; Fan D Biochem Biophys Res Commun; 2006 Jul; 345(3):1092-8. PubMed ID: 16714000 [TBL] [Abstract][Full Text] [Related]
19. Notch 1 promotes cisplatin-resistant gastric cancer formation by upregulating lncRNA AK022798 expression. Hang Q; Sun R; Jiang C; Li Y Anticancer Drugs; 2015 Jul; 26(6):632-40. PubMed ID: 25763542 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells. Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]